Skip to main content
Home
Home

  • People
  • Events
    Map of the Middle East
    Wed, June 10, 2026 | 5 pm - 6:45 pm
    The Middle East and US Foreign Policy: What Happens Next? See Details
    AI in Health Conference_Banner Image
    Science and Technology Policy
    Tue, Sep. 15 - Thu, Sep. 17, 2026 | 8 am - 6 pm
    AI in Health Conference See Details
    SynBio-Crop
    Science and Technology Policy
    Fri, Sep. 18, 2026 | 9 am - 5 pm
    Synthetic Biology at the Intersection of Science, Ethics, and Policy See Details
  • Podcasts
  • Research Programs
  • Research & Commentary
  • Press
  • Support
  • About
  • Newsletter
  • Search
  • Research
  • Twitter
  • Facebook
  • instagram
  • Linkedin
  • Youtube
  • Newsletter
  • Economics & Finance
  • Energy
  • Foreign Policy
  • Domestic Policy
  • Health & Science
  • All Publications
Drug Policy | Policy Brief

Mapping Hemp Products’ Legal Status Across US States

December 6, 2024 | Katharine Harris, Victoria Jupp, Lisa Pittman
Wooden judge hammer and sound block with seeds and flower of marijuana

Table of Contents

Author(s)

Katharine Harris

Alfred C. Glassell, III, Fellow in Drug Policy

Victoria Jupp

Policy Assistant to the Director | Director, Executive Policy Research Program

Lisa Pittman

Nonresident Fellow in Drug Policy

Share this Publication

  • Facebook
  • Twitter
  • Email
  • Linkedin
  • Print This Publication
  • Cite This Publication

    Katharine Neill Harris, Victoria Jupp, and Lisa Pittman, “Mapping Hemp Products’ Legal Status Across US States,” Rice University’s Baker Institute for Public Policy, December 6, 2024, https://doi.org/10.25613/5C1S-Q789.

    Copy Citation

Tags

Drug policyHempCannabisSynthetic cannabinoids

Understanding Hemp Products

Hemp is a strain of the cannabis plant that is legally defined as having less than 0.3% delta-9 tetrahydrocannabinol (THC) by dry weight. Delta-9 THC is the primary psychoactive compound in cannabis responsible for marijuana’s so-called high feeling. By requiring hemp to have a low concentration of delta-9 THC, lawmakers meant to ensure that the plant would not cause impairment.

The delta-9 THC threshold for hemp was effective — until it wasn’t. By passing the 2018 Farm Bill, Congress broadly legalized the production and sale of hemp, invigorating a vast market for hemp-derived products. Contrary to the expectations of some lawmakers, many popular hemp products do cause impairment. In jurisdictions with few regulations, it is not uncommon to find hemp products that are more potent than what is allowed in many recreational marijuana markets.

Hemp products with legal amounts of delta-9 THC are available in most states. Manufacturers also use hemp to produce THC isomers — compounds similar to delta-9 THC in structure and effects. 

For more information on hemp-derived cannabinoids, see the Drug Policy Program’s brief detailing popular cannabis compounds here.

Overview of State Laws on Hemp-Derived Cannabinoids

States are cracking down on the hemp-derived cannabinoid market in a variety of ways. Some have enacted age restrictions without addressing issues such as product potency. Others have restricted product potency by applying the 0.3% delta-9 THC threshold to all THC isomers. However, the weight-based metric still allows heavier items — drinks, edibles, etc. — to contain potent amounts of THC. To account for this, some states have also specified milligram caps for total THC content.

Other states have banned hemp-derived cannabinoids that are created through a chemical process. This effectively removes many impairing hemp products from the market, because naturally occurring compounds such as delta-8 THC exist in minuscule amounts that do not have significant effects unless they are modified with other chemicals.

Several states that allow adult medical and recreational use of marijuana have enacted strict measures to tamp down the hemp market, while others have moved toward regulating hemp and marijuana under a single cannabis umbrella.

Map: Hemp Products’ Legal Status in US States

The map below shows the legal status of impairing hemp-derived cannabinoids in each state:

 
Source: Katharine Neill Harris and Uilvim Ettore Gardin Franco.
Note: Rice students, Bianca Shutz, Doug Calvillo, Quinn Healy, Sara Davidson, Jeffery Liu, and Imani Hill, aided with the data collection process.

 

Legend Directory
LegalImpairing hemp-derived cannabinoids are legally available with few restrictions.
Legal, Some RestrictionsImpairing hemp-derived cannabinoids are legally available with some restrictions, such as milligram caps on total THC content, prohibitions on certain product types, and limits on where products can be sold.
Heavily RestrictedCannabinoids that are produced through isomerization are prohibited, or potency caps are so low that legal products are unlikely to cause impairment. Hemp-derived delta-9 THC is still legal.
IllegalCannabinoids that are produced through isomerization are prohibited, and hemp with any detectable amount of THC is prohibited or only available where marijuana is sold.
MixedThe state has taken the position that impairing hemp-derived cannabinoids are illegal, but enforcement is so limited or locally variable that one classification does not apply to the whole jurisdiction.

 

Term Index
Tetrahydrocannabinolic Acid (THCa)Refers to THCa, a naturally occurring compound in hemp and marijuana plants that converts into delta-9 THC when it is heated. Some states require the combined amount of THCa and delta-9 THC to be less than 0.3% concentration by weight for legal hemp products in order to limit product potency.
Total Tetrahydrocannabinol (THC)Refers to state potency limits that restrict the total concentration of all cannabinoids, including THCa and THC isomers, such as delta-8, delta-9, delta-10, etc.
IsomerizationRefers to the chemical process by which naturally occurring compounds in the hemp plant are modified or transformed into other cannabinoids. State laws may use other terms to refer to this process, including “chemical conversion,” “synthetically derived,” and “chemically modified” hemp derivatives.

 

 

This material may be quoted or reproduced without prior permission, provided appropriate credit is given to the author and Rice University’s Baker Institute for Public Policy. The views expressed herein are those of the individual author(s), and do not necessarily represent the views of Rice University’s Baker Institute for Public Policy.

© 2024 Rice University’s Baker Institute for Public Policy
https://doi.org/10.25613/5C1S-Q789
  • Print This Publication
  • Share
    • Facebook
    • Twitter
    • Email
    • Linkedin

Related Research

Cannabis cultivation workers trimming hemp plants.
Center for Health Policy | Drug Policy | Policy Brief

How US Hemp Policy Can Balance Consumer Access and Public Health

Read More
Macro close up of droplet dosing a biological and ecological hemp
Texas Briefing | Drug Policy | Podcast

New Texas Hemp Rules and the Future of Cannabis Policy

Read More
Prescription opioid medication pills spilled onto table
Drug Policy | Press Release

Drug policy expert available to speak about fentanyl executive order

Read More
  • Contact Us
  • Donate Now
  • Press
  • Membership
  • Careers
  • Student Opportunities
  • About the Institute
  • Rice.edu

6100 Main Street
Baker Hall MS-40, Suite 120
Houston, TX 77005

Email: [email protected]
Phone: 713-348-4683
Fax: 713-348-5993

  • Twitter
  • Facebook
  • instagram
  • Linkedin
  • Youtube
  • Newsletter
  • © Rice University's Baker Institute for Public Policy
  • Web Accessibility
  • Privacy Policy